Two new FDA Drug Supply Chain Security Act Guidances to help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s move to Electronic Tracking

The DSCSA, enacted in 2013, requires entities in the pharmaceutical supply chain to implement security measures to prevent the introduction of counterfeit and illegitimate drugs into the market. One of these measures is the requirement to track the movement of prescription drugs electronically at the package level….
By: Nelson Mullins Riley & Scarborough LLP
Previous Story

More Guidance Released from FDA for Drug Supply Chain Security Act Compliance

Next Story

Healthcare Regulatory Check-up Newsletter | July 2023 Recap